. 2015 Apr 1;34(1):16. doi: 10.1186/s40101-015-0054-6

Table 3.

Age-adjusted characteristics of the study population limited to subjects with HbA1c (≤Q3)

	Total subjects				Low BMI				High BMI
	HbA _1c level quintiles				HbA _1c level quintiles				HbA _1c level quintiles
	Q1 (low)	Q2	Q3 (high)	P	Q1 (low)	Q2	Q3 (high)	P	Q1 (low)	Q2	Q3 (high)	P
No. at risk	190	205	258		103	102	127		87	103	131
Age, year	70.3 ± 6.3	70.5 ± 7.6	70.3 ± 6.7		71.5 ± 6.7	71.5 ± 8.1	70.2 ± 7.2		68.9 ± 5.6	69.5 ± 6.9	70.4 ± 6.1
Systolic blood pressure, mmHg	144	147	143	0.187	140	142	140	0.721	149	152	147	0.223
Antihypertensive medication use, %	35.9	30.1	38.9	0.132	27.4	24.8	30.3	0.642	46.1	35.2	47.0	0.144
Body mass index, kg/m²	22.8	23.5	23.1	0.062	20.8	20.9	20.8	0.674	25.1	26.0	25.4	0.008
Current drinker, %	53.1	52.3	51.5	0.942	60.6	50.4	47.4	0.121	43.7	54.1	55.9	0.179
Current smoker, %	20.5	17.6	24.0	0.242	23.8	21.0	29.2	0.334	16.8	14.5	18.7	0.692
Serum triglycerides, mg/dL	97	119	105	0.003	91	101	92	0.284	105	137	117	0.010
Serum HDL-cholesterol, mg/dL	56	54	56	0.319	60	56	58	0.157	51	52	54	0.321
Serum aspartate aminotransferase (AST), IU/L	25	25	24	0.263	26	25	23	0.127	24	26	24	0.322
Glucose-lowering medication use, %	2.1	2.0	1.2	0.699	3.9	3.0	0.8	0.279	0.0	1.0	1.6	0.481
Lipid-lowering medication use, %	3.2	5.9	5.4	0.410	2.9	5.9	4.7	0.589	3.4	5.8	6.1	0.659
History of cardiovascular disease, %	9.5	8.2	12.4	0.302	7.6	4.7	8.9	0.471	12.2	11.8	15.4	0.675
Taking medication for cardiovascular disease, %	7.4	7.3	11.3	0.218	5.6	3.7	8.2	0.354	9.8	10.8	14.0	0.585
Serum creatinine, mg/dL	0.98	0.92	0.92	0.055	1.00	0.93	0.92	0.193	0.96	0.91	0.93	0.334
Glomerular filtration rate (GFR), mL/min/1.73 m²	63.7	67.3	67.5	0.036	62.7	68.4	69.0	0.020	64.8	66.4	66.0	0.792

Age: mean ± standard deviation. Low BMI consists of BMI <23 kg/m² and high BMI consists of BMI ≥23 kg/m². P: age-adjusted values of P for the trend. BMI: body mass index.